Calamos Advisors LLC Vericel Corp Transaction History

Calamos Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$35.2 - $52.6 $2.98 Million - $4.46 Million	-84,765 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$46.35 - $59.75 $2.59 Million - $3.34 Million	-55,966 Reduced 39.77%	84,765 $4.14 Million
Q2 2021 Jul 22, 2021	SELL	$47.2 - $67.81 $1 Million - $1.44 Million	-21,224 Reduced 13.1%	140,731 $7.39 Million
Q1 2021 Apr 12, 2021	SELL	$30.93 - $59.48 $1.23 Million - $2.37 Million	-39,869 Reduced 19.75%	161,955 $9 Million
Q4 2020 Jan 27, 2021	BUY	$18.53 - $31.5 $2.51 Million - $4.27 Million	135,458 Added 204.11%	201,824 $6.23 Million
Q3 2020 Oct 26, 2020	BUY	$14.68 - $19.12 $974,252 - $1.27 Million	66,366 New	66,366 $1.23 Million
Q2 2020 Jul 27, 2020	SELL	$8.5 - $15.82 $368,500 - $685,844	-43,353 Closed	0 $0
Q1 2020 Apr 28, 2020	SELL	$7.25 - $19.22 $1.24 Million - $3.28 Million	-170,560 Reduced 79.73%	43,353 $398,000
Q4 2019 Jan 15, 2020	SELL	$13.77 - $19.2 $2.65 Million - $3.69 Million	-192,264 Reduced 47.34%	213,913 $3.72 Million
Q3 2019 Oct 21, 2019	BUY	$14.93 - $19.83 $78,576 - $104,365	5,263 Added 1.31%	406,177 $6.15 Million
Q2 2019 Aug 07, 2019	BUY	$15.01 - $18.89 $6.02 Million - $7.57 Million	400,914 New	400,914 $7.57 Million

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.